Beam Therapeutics (BEAM) Times Interest Earned (2019 - 2026)
Beam Therapeutics' (BEAM) quarterly Times Interest Earned came in at -$111.68 in Q1 2026, up 89.23% year-on-year from -$59.02 in Q1 2025, and up 98.86% on a QoQ basis from -$9754.7 in Q3 2025.
Beam Therapeutics (BEAM) Times Interest Earned (2019 - 2026) Analysis & Trends
Beam Therapeutics (BEAM) has 8 years of Times Interest Earned data on file, last reported at -$111.68 in Q1 2026.
- On a quarterly basis, Times Interest Earned rose 89.23% year-over-year to -$111.68 in Q1 2026; TTM through Mar 2026 was -$7.68, a 99.79% increase from a year earlier, with the FY2025 full-year figure at -$7.13, down 651.5% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$111.68, up from -$9754.7 in the prior quarter.
- Over the last five years, Times Interest Earned for BEAM reached as high as $5.91 in Q4 2023 and fell as low as -$53252.0 in Q3 2024.
- Historically, Times Interest Earned has averaged -$4337.5 across 5 years, with a median of -$233.32 in 2023.
- Across the five-year window, Times Interest Earned surged 100.51% in 2023 and tumbled 23804.3% in 2024, its largest moves.
- Year by year, Times Interest Earned stood at -$1170.9 in 2022, then surged by 100.51% to $5.91 in 2023, then plunged by 167.79% to -$4.01 in 2024, then sank by 243179.8% to -$9754.7 in 2025, then surged by 98.86% to -$111.68 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$111.68 in Q1 2026, -$9754.7 in Q3 2025, and -$2310.6 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Beam Therapeutics | 2.68 Bn | 2.68 Bn | - | -111.68 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -111.68 |
| Sep 30, 2025 | -9,754.69 |
| Jun 30, 2025 | -2,310.60 |
| Mar 31, 2025 | -1,037.27 |
| Dec 31, 2024 | -4.01 |
| Sep 30, 2024 | -53,252.00 |
| Jun 30, 2024 | -647.50 |
| Mar 31, 2024 | -243.87 |
| Dec 31, 2023 | 5.91 |
| Sep 30, 2023 | -222.77 |
| Jun 30, 2023 | -82.58 |
| Mar 31, 2023 | -543.56 |
| Dec 31, 2022 | -1,170.86 |
| Sep 30, 2022 | -19.84 |
| Jun 30, 2022 | -0.85 |
| Mar 31, 2022 | -3.80 |
| Dec 31, 2021 | -14.40 |
| Sep 30, 2021 | -22.77 |
| Jun 30, 2021 | -25.53 |
| Mar 31, 2021 | -118.92 |